We hypothesize that the mechanism of this decrease in mild physical activity may result from persistent side effects of maintenance treatments (such as arthralgias from aromatase inhibitors) and/or establishment of new lifestyle habits during acute cancer treatment that persist beyond the period of intense treatment. The gene discussed is CYP19A1; the disease is cancer.